IgLON5 autoimmunity secondary to immune checkpoint inhibitor

IgLON5 autoimmunity is characterized by a diverse range of clinical presentations, including neuropsychiatric symptoms, sleep disturbances, gait instability, and bulbar symptoms, that are usually insidiously progressive. While some individuals with specific HLA haplotypes may be more susceptible to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of neuroimmunology 2025-02, Vol.399, p.578516, Article 578516
Hauptverfasser:	Itoh, Christopher, Swart, Grace, St. Louis, Erik, Gandhi, Manish, Dubey, Divyanshu
Format:	Artikel
Sprache:	eng
Schlagworte:	Autoimmune encephalitis Immune checkpoint inhibitor Immune mediated adverse event
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!